SAN DIEGO--(BUSINESS WIRE)--Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the appointment of Kenna L. Anderes, PhD, as senior vice president of translational medicine. “Dr. Anderes’ background and leadership experience will be a great addition to our efforts of providing precision medicine at Molecular Response,” said Cyrus Mirsaidi. “Kenna is an accomplished leader who is known for her ability to guide multidisciplinary teams by leveraging target validation, mechanism of action, biomarker and co-diagnostic tools to ensure scientific validation.”
